Mario C.B. Raviglione is Full Professor of Global Health at the University of Milan, Italy, that he joined in 2018 and co-director of the Centre for Multidisciplinary Research on Health Science (MACH). Between 1991 and 2017, he worked at the World Health Organization (WHO) in Geneva where he was Director of the Global Tuberculosis (TB) Programme (2003-2017) and responsible for global policies and standards on TB care, control and research.

He joined WHO in 1991. He contributed to the development of the DOTS strategy in 1994 and set up the global drug-resistance surveillance project (1994) and the global TB surveillance & monitoring system (1995). He conceived and directed the development of the Stop TB Strategy in 2006 and of the current End TB Strategy approved by the World Health Assembly in 2024. As a WHO official he worked with more than 50 countries worldwide. He graduated from Turin University, and trained in internal medicine, infectious diseases and AIDS at Cabrini Medical Centre, New York, and Beth Israel Hospital, Harvard Medical School, Boston. He has authored >350 publications on TB, AIDS, infectious diseases, COVID-19 and global health, and additional book chapters, guidelines and policy documents. He was editor of two editions (2006, 2009) of “Tuberculosis – A comprehensive International Approach“ (Informa Healthcare) and of “Essential Tuberculosis” (Springer, 2021). He conceived and was chief editor of “Global Health Essentials” (Springer, 2023), a comprehensive manual on global health with 150 reputable authors from 30 countries. He is among the top 10 most cited authors in the TB field and the top 50 Italian scientists in clinical fields. His h-index is 119 and his work has been cited >66,000 times. He has served as a visiting professor and taught at major universities worldwide and has lectured at top international health conferences in over 60 countries. He received several international awards for his work in global health and tuberculosis.